-
1 Comment
Hin Sang Group (International) Holding Co. Ltd is currently in a long term downtrend where the price is trading 31.4% below its 200 day moving average.
From a valuation standpoint, the stock is 20.0% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 3.6.
Hin Sang Group (International) Holding Co. Ltd's total revenue sank by 51.6% to $44M since the same quarter in the previous year.
Its net income has dropped by 161.5% to $-5M since the same quarter in the previous year.
Finally, its free cash flow fell by 532.6% to $-37M since the same quarter in the previous year.
Based on the above factors, Hin Sang Group (International) Holding Co. Ltd gets an overall score of 0/5.
| ISIN | KYG4590V1023 |
|---|---|
| Exchange | HK |
| CurrencyCode | HKD |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | 197M |
|---|---|
| PE Ratio | None |
| Beta | 0.08 |
| Target Price | None |
| Dividend Yield | None |
Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, engages in the manufacture, marketing, and sale of healthcare products for children in Hong Kong and Mainland China. It operates in four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, and King's Antiseptic brands. Its Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products under the Pahmi, Enear, Vcnic, Zici, and Sunew brands; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the trading, distribution, and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. Its Healthcare segment engages in the provision of Chinese medical healthcare, including as medical treatment and consultation by Chinese physicians for mothers and children; and development of mother and child related health products, medical center, and related services. The company is also involved in property holding activities. It sells its products through a network of distributors; and online. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. Is a subsidiary of Genwealth Group Holding Company Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6893.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
